Open AccessUrine Biomarkers for Prostate Cancer Diagnosis and Progression
Author(s) -
Jeremy Clark,
Rachel Hurst,
Mark S. Winterbone,
Hardeve Pahndha,
Antoinnette Perry,
Sophie McGrath,
Richard Morgan,
Adele E. Connor,
Asia C. Jordan,
Deirdre Winrow,
Christopher S. Cooper
Publication year - 2021
Publication title -
société internationale d'urologie journal
Language(s) - English
Resource type - Journals
ISSN - 2563-6499
DOI - 10.48083/sawc9585
Subject(s) - prostate cancer , urine , medicine , risk stratification , biomarker , stage (stratigraphy) , oncology , cancer , chemistry , biology , paleontology , biochemistry
Prostate cancer (PCa) can be highly heterogeneous and multifocal, and accurate assessment of the volume, grade, and stage of PCa in situ is not a simple task. Urine has been investigated as a source of PCa biomarkers for over 70 years, and there is now strong evidence that analysis of urine could provide more accurate diagnosis and a better risk stratification that could aid clinical decisions regarding disease surveillance and treatment. Urine diagnostics is a developing area, moving towards multiomic biomarker integration for improved diagnostic performance. Urine tests developed by strong collaborations between scientists and clinicians have the potential to provide targeted and meaningful data that can guide treatment and improve men’s lives.